•  
  •  
 

Problems and perspectives in pharmaceutics and drug discovery

Abstract

There have been developed the optimal composition of diuretic species“Stiflos” made of medicinal herbs, supplied with sufficient raw material base in the territory of the Republic.As a result of the combined experimental and clinical studies, it was recommended as an effective diuretic for cardiovascular system diseases associated with kidney, liver, urinary tract and circulatory failure.

First Page

42

Last Page

45

References

1.Opredelitel rasteniy SredneyAzii. Ktiteticheskiy konspekt floni, Tashkent, Izdatelstvo "Fan”, -1993, -Т.10, -S. 615. 2.. Flora Uzbekistana. Tashkent, -1962, - T.6.-S. 195-197. 3. Raxmankulov U, Kasimov Sh.Z., TayjanovK, Sid) akin G.P. Nalichiye ?-laktonov it vidovsem. Asteraceae flori Sredney Azii //Past, resursi. -1979. - T.15, - Vip.l, - S. 79-89. 4. Perfilova V.N., Dyakov A.A., Tyurenkov IN. Kardioprotektivnoye deystviye ferulovoy kislorit pri stressornom povrejdenii serdsa //Eksperim. i klinich. farmakologiya. - 2005. - T. 68, - 5. - S. 19-22. 5. Xramov V.A., Dmitriyenko N. V. Xlorogenovaya kislora v listyax i liqfilizirovannuxekstraktax stevii //Xim - formats, jum. - 2000. - T.34, -11. - S.34-35. 6. Hou Y.Z. etal.Ferulic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin ПНЕиг. J. Pharmacol. - 2004. - VoL 199, -l.-P 85-90. 7. Lopez-Lazaro M. Distribution and biological activities of the flavonoid luteolin //Mini. Rev. Med. Chem., - 2009. - Vol. 9 (1), - P. 31-59. 8. Theoharides T.C., Kempuraj D., Uiopoulou B.P. Mast cells, T cells and inhibition by luteolin: implications for the pathogenesis and treatment of multiple sclerosis f/Adv. Exp. Med. Biol., - 2007. - Vol. 601, - P. 423-430. 9.. PopovaN.V., DixtyarevS.I., Maslova N.F., Litvinenko V.I., Almakayeva L.G., Lecheniye zabolevaniypochek fitoximicheskimi prepararami /7 Ftorerapya. Chasopis, - 2011. -4, - C. 40-44. 10. Aim J., Lee H, Kim S., ParkJ., Ha T. Tne anti-obesitу effect of quercetin is mediated by the AMPK and MiPK signaling pathways // Biochem. Biophys. Res. Commun., - 2008, - Vol. 373, -P. 545-549. 11. Kleemann R., Verschuren L., Morrison M., Zadelaar S., van Erk, M. J., Wielinga, P. Y., Kooistra, T. Anti-inflammatory , anti-proliferative and anti-atherosclerotic effects of quercetin in human in vivo models //Atherosclerosis, - 2011, - Vol. 218.-P. 44-52. 12. Gibellini L., Pinri M, Nasi M., Montagna J.P, De Biasi S., Roat E., Benoncelli L., Cooper E.L., Cossarizza A. Queixetin and cancer chemoprevenrion //Evid. Based. Complement Alternat. Med., - 2011. doi: 10.1093/ecam/neq053. 13. SraedlerD., Idrizi E., Ketizaoui B.H., Juillerat-JeanneretL. Dtvg combinations with queicerin: doxonibicinplus queice-tin in human breast cancer cells // Cancer Chemother. Pharmacol., - 2011, - Vol. 68, -P 1161-1172.

Share

COinS